✦ LIBER ✦

Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner – meta-analysis of six randomized trials

✍ Scribed by Y. Cao; C. Liao; A. Tan; L. Liu; Z. Mo; F. Gao

Book ID: 109043358
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 216 KB
Volume: 12
Category: Article
ISSN: 1462-8910
DOI: 10.1111/j.1463-1318.2009.01803.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Capecitabine/oxaliplatin as first-line t

Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis

✍ G. Zhao; P. Gao; K. H. Yang; J. H. Tian; B. Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

601 ORAL Infusional 5-fluorouracil/folin

601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Capecitabine plus oxaliplatin (xelox) ve

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

✍ Andrea Angelo Martoni; Carmine Pinto; Francesca Di Fabio; Giorgio Lelli; Fabiola 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 176 KB

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPE

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS 5-FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE FIRST LINE TREATMENT OF METASTASIS COLORECTAL CANCER IN TAIWAN

✍ HH Chen; CS Chang; LT Chen; WT Chen; TC Hsu; JY Wang; CY Wen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

295 Capecitabine plus irinotecan (CAPIRI

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

✍ A. Grothey; K. Jordan; O. Kellner; C. Constantin; G. Dietrich; H. Kroening; L. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 326 KB